Completed from United Kingdom
I took this course to get a solid grounding in pharmaceutical economics and it definitely delivered. The lessons were clear and the practical exercises, like the budgeting workshop where we simulated a national drug formulary, helped me grasp concepts that were previously just theory. The course materials, especially the video interviews with industry experts, were spot‑on and kept me engaged. While the pace was a bit fast at times, the overall experience was enjoyable and I now feel confident applying health‑economic evaluation methods in my current role at a UK NHS trust.
The Advanced Certificate in Health Economics (Pharmaceutical) exceeded my expectations. The curriculum aligned perfectly with my goal to transition into a health‑technology assessment role. I especially valued the module on cost‑effectiveness modelling, where I built an Excel‑based Markov model for a new oncology drug and received actionable feedback from the instructor. The reading list, featuring up‑to‑date WHO reports and real‑world case studies, was both rigorous and relevant. Overall, the learning platform was user‑friendly and the live webinars facilitated deep discussions. I feel fully equipped to contribute to pricing strategy projects at my organization.
Wow! This course was a game‑changer for my career aspirations. I wanted to learn how to assess the value of new medicines, and the instructor walked us through a real‑world case study on a diabetes drug, showing how to calculate the incremental cost‑effectiveness ratio (ICER). The hands‑on assignments using R for data analysis were incredibly useful – I can now run my own health‑economic models at my hospital. The course pack was up‑to‑date with Indian market data, which made everything feel directly applicable. I'm thrilled with the knowledge I gained and can't wait to use it in upcoming policy discussions.
The Advanced Health Economics certificate offered a thorough and detailed exploration of pharmaceutical pricing and reimbursement strategies. My learning goal was to understand how health technology assessments are conducted in emerging markets, and the course delivered concrete tools—like the step‑by‑step guide to building a budget impact model that I have already adapted for a South African vaccine rollout. The reading materials were well‑curated, blending academic papers with industry reports, which made the content both credible and relevant. The detailed feedback on assignments helped me refine my analytical skills. Overall, the program was intensive but highly rewarding.
